mRNA vaccines for the future of medicine 15/09/2026 Healthcare Coronavirus Innovative drugs The COVID-19 pandemic transformed mRNA technology into a large-scale clinical platform and demonstrated its ability to... Partners - GENESIS Biomed
ORYZON to participate in upcoming events in September and October 11/09/2026 Healthcare Innovative drugs International Oryzon Genomics will participate in several international investment and capital markets events in the United States and... Partners - Oryzon Genomics
Biotechnology is driving earlier and more personalised approaches to sepsis 13/09/2026 Healthcare In vitro diagnostics Personalized medicine Together with clinical experts, researchers and our partner Viva In Vitro Diagnostics, we analyse the main challenges in... AseBio - VIVA IN VITRO
Sepsis causes 11 million deaths every year, while new biomarkers are paving the way for a ... 13/09/2026 VIVA IN VITRO In Spain, around 50,000 people are affected by sepsis each year and approximately 17,000 die, highlighting the... AseBio - VIVA IN VITRO
CONNECTA Therapeutics Announces Financing to Advance Clinical Development of Fragile X Sy... 10/09/2026 Healthcare Rare diseases Innovative drugs €3.1 million financing led by new investor Clave Capital, with participation from existing investors. Partners - CONNECTA THERAPEUTICS
#BIOSPAIN2026 | Abstract – Accelerating Cell & Gene Therapy Impact through analytical exce... 08/09/2026 Healthcare Innovative drugs Advanced therapies Cell and gene therapies are transforming biomedical innovation, but their development presents significant challenges in... Partners
BCN HEALTH publishes a systematic review highlighting the cost effectiveness of novel neph... 08/09/2026 Healthcare Access to innovation Innovative drugs BCN HEALTH has published the study “Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2... Partners - BCN Health
Viva in Vitro and Vall d’Hebron will investigate the potential of functional NLRP3 biomark... 07/09/2026 Healthcare Drug discovery Personalized medicine The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of... Partners - VIVA IN VITRO
iPremom raises €15m to transform pregnancy care with molecular diagnostics 03/09/2026 Healthcare Access to innovation Personalized medicine iPremom, a molecular diagnostics company dedicated to the earliest prediction of pregnancy complications, has raised... Partners - Asabys Partners
BCN HEALTH presents new analyses on hepatitis delta vs. hepatitis B healthcare costs in Sp... 03/09/2026 Healthcare Access to innovation Innovative drugs BCN HEALTH participated in the European Association for the Study of the Liver (EASL) International Liver Congress (ILC... Partners - BCN Health
